Session I: September 8
The Impact of COVID-19 On The Prostate Cancer Racial Disparity
COVID-19 delayed prostate cancer early detection screening and treatments. It also ushered in an increased use of telemedicine for prostate cancer care which is anticipated to expand and become more of a standard of care. This session assesd the impact of the pandemic, with a focus on how the increased use of telemedicine will impact the prostate cancer racial disparity based on the experiences and perspectives of doctors and patients.
Welcome and Opening Remarks: Mr. Thomas Farrington, President and Founder, PHEN
Moderator: Edith Mitchell, MD, MACP, FCPP, FRCP, Clinical Professor of Medicine and Medical Oncology; Department of Medical Oncology, Director, Center to Eliminate Cancer Disparities, Associate Director, Diversity Affairs, Sidney Kimmel Cancer Center at Jefferson
Session One Recording: